Results summary | View all lists in L2L MDB | View all genes in R03B.profile.u50 |
Down-regulated at 48 hr following treatment of peripheral blood mononuclear cells (PBMC) with recombinant IL-2. enrichment: 4.57-fold |
![]() |
![]() | |||||||||||
Probe ID | Name | G | T | D | X | E | P | R | C | S | ![]() |
![]() |
Description |
201041_S_AT | DUSP1 | X | E | P | ![]() |
![]() |
dual specificity phosphatase 1 | ||||||
206493_AT | ITGA2B | C | S | ![]() |
![]() |
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | |||||||
213280_AT | GARNL4 | S | ![]() |
![]() |
GTPase activating Rap/RanGAP domain-like 4 | ||||||||
204526_S_AT | TBC1D8 | G | S | ![]() |
![]() |
TBC1 domain family, member 8 (with GRAM domain) | |||||||
209185_S_AT | IRS2 | G | D | E | S | ![]() |
![]() |
insulin receptor substrate 2 | |||||
209184_S_AT | IRS2 | G | D | E | S | ![]() |
![]() |
insulin receptor substrate 2 |